Healthcare provider profile · identity verified

Michele Dawn Fleak, M.D.,

Internal Medicine · DOVER, OH · NPI 1033193347

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1324	353
Levothyroxine Sodium	Levothyroxine Sodium	975	228
Amlodipine Besylate	Amlodipine Besylate	878	219
Lisinopril	Lisinopril	854	216
Rosuvastatin Calcium	Rosuvastatin Calcium	734	193
Losartan Potassium	Losartan Potassium	711	181
Metformin Hcl	Metformin Hcl	649	155
Omeprazole	Omeprazole	536	145
Metoprolol Succinate	Metoprolol Succinate	495	133
Hydrochlorothiazide	Hydrochlorothiazide	439	124
Pantoprazole Sodium	Pantoprazole Sodium	439	114
Simvastatin	Simvastatin	358	91
Gabapentin	Gabapentin	337	73
Metoprolol Tartrate	Metoprolol Tartrate	323	81
Pravastatin Sodium	Pravastatin Sodium	322	80
Eliquis	Apixaban	311	60
Glimepiride	Glimepiride	307	76
Alprazolam	Alprazolam	289	67
Furosemide	Furosemide	274	86
Hydralazine Hcl	Hydralazine Hcl	256	52
Escitalopram Oxalate	Escitalopram Oxalate	244	68
Potassium Chloride	Potassium Chloride	221	50
Sertraline Hcl	Sertraline Hcl	220	48
Tramadol Hcl	Tramadol Hcl	206	41
Clopidogrel	Clopidogrel Bisulfate	197	52
Carvedilol	Carvedilol	195	44
Warfarin Sodium	Warfarin Sodium	191	38
Trazodone Hcl	Trazodone Hcl	182	55
Albuterol Sulfate Hfa	Albuterol Sulfate	176	77
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	173	46
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	165	37
Alendronate Sodium	Alendronate Sodium	161	44
Synthroid	Levothyroxine Sodium	156	46
Zolpidem Tartrate	Zolpidem Tartrate	142	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	137	33
Citalopram Hbr	Citalopram Hydrobromide	135	34
Meloxicam	Meloxicam	135	38
Allopurinol	Allopurinol	131	41
Buspirone Hcl	Buspirone Hcl	126	31
Tamsulosin Hcl	Tamsulosin Hcl	125	36
Spironolactone	Spironolactone	119	29
Atenolol	Atenolol	110	26
Venlafaxine Hcl Er	Venlafaxine Hcl	110	27
Famotidine	Famotidine	107	33
Fluticasone Propionate	Fluticasone Propionate	106	36
Paroxetine Hcl	Paroxetine Hcl	104	26
Montelukast Sodium	Montelukast Sodium	103	29
Fluoxetine Hcl	Fluoxetine Hcl	101	18
Oxybutynin Chloride Er	Oxybutynin Chloride	95	24
Prednisone	Prednisone	95	74
Lorazepam	Lorazepam	79	19
Xarelto	Rivaroxaban	78	14
Lovastatin	Lovastatin	77	18
Ozempic	Semaglutide	77	22
Duloxetine Hcl	Duloxetine Hcl	76	21
Donepezil Hcl	Donepezil Hcl	74	18
Diclofenac Sodium	Diclofenac Sodium	71	20
Ezetimibe	Ezetimibe	69	15
Bupropion Xl	Bupropion Hcl	66	19
Jardiance	Empagliflozin	66	16
Esomeprazole Magnesium	Esomeprazole Magnesium	61	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	15
Azithromycin	Azithromycin	53	49
Bumetanide	Bumetanide	53	13
Metformin Hcl Er	Metformin Hcl	53	18
Clonazepam	Clonazepam	51	suppressed
Glipizide	Glipizide	51	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	11
Enalapril Maleate	Enalapril Maleate	49	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	47	suppressed
Arnuity Ellipta	Fluticasone Furoate	46	11
Mirtazapine	Mirtazapine	46	suppressed
Clonidine Hcl	Clonidine Hcl	45	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	suppressed
Benazepril Hcl	Benazepril Hcl	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	36
Nifedipine Er	Nifedipine	39	suppressed
Lansoprazole	Lansoprazole	38	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	35
Valsartan	Valsartan	37	11
Jantoven	Warfarin Sodium	36	14
Januvia	Sitagliptin Phosphate	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	27
Fenofibrate	Fenofibrate	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Klor-Con M20	Potassium Chloride	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	23
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Nystatin	Nystatin	28	18
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	28	suppressed
Sucralfate	Sucralfate	28	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Cefdinir	Cefdinir	25	21
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	11
Irbesartan	Irbesartan	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	22	12
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	15
Pregabalin	Pregabalin	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Primidone	Primidone	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Temazepam	Temazepam	19	suppressed
Topiramate	Topiramate	19	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	19	suppressed
Cilostazol	Cilostazol	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Repaglinide	Repaglinide	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Verapamil Sr	Verapamil Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Ramipril	Ramipril	14	suppressed
Unifine Pentips	Pen Needle, Diabetic	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Cephalexin	Cephalexin	13	12
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Livalo	Pitavastatin Calcium	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Fluconazole	Fluconazole	12	12
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Naproxen	Naproxen	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Linzess	Linaclotide	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error